A recent report from Goldman Sachs, featured in an article on News Max Finance strongly indicates that regenerative medicine is continuing to be a an attractive option for investment.
The GS report is entitled “The Coming Age of Regenerative Medicine”, and to quote from it “venture capital in companies pursuing regenerative medicine increased from $296 million in 2011 to $807 million in 2016, growing roughly 34% year-over-year.”
The report also states that 80 regenerative-medicine companies have gained investment with the last 3 years, representING approximately 50% of the top VC deals in 2015 and 2016.
Grace Century President and Director of Research Scott Wolf said “This continues to show that our research was right 6 years ago. Regenerative medicine is the new Gold Rush.”
Read the full article on News Max Finance here
Annual Investment Meeting (AIM) Startup 2017 kicked off in Dubai, under the patronage of his Highness Sheikh Mohammed Bin Rashid al Maktoum, Vice President and Prime Minister of the U.A.E. and Ruler of Dubai. In cooperation with the Ministry of the Economy, and over 3 days, attendees were able to network and listen to presentations with multiple speakers from different niches within finance.
The event is a platform where disruptive Start-ups gather to present their innovative products and services on a truly global stage.
The discussions gave a unique insight to the present and future climate that ‘Early” stage firms might be confronted with. These included many discussions from Building Global companies all the way to the “Do’s and Don’ts” with the interaction of Government agencies. The event was highlighted by providing a platform for 84 young companies, from many countries, to have an opportunity to be in front of interested funding partners.
Grace Century Members Jennifer Doyle, Vice President of Administration and CEO, Scott Wolf attended. Wolf comments “I was thoroughly impressed with the innovations brought to the competition, especially the high concentration of companies from the Emirates. It is a testament to how the country has provided a nurturing infrastructure and why it is home to some many “incubators””.
Presenting to the groups were Start-ups and early stage firms coming from Food & Beverage, Agriculture, Renewable Energy, Healthcare, and Education.
Scott Wolf concludes “Expos like this are not only invaluable to see possible “project flow” for our firm, but to keep on finger on the rapidly changing landscape in this stage of firms and the changing technologies. The fact that it was in our “backyard” of Dubai was an added benefit”.
It has been announced that Grace Century President and Director of Research Scott Wolf has has appointed to the Business Advisory Board of Provia Laboratories LLC, Grace Century’s dental stem cell storage project partner.
Scott has tirelessly worked to help Provia with many important business functions since becoming involved with them in 2014, including contributing to Provia’s overall strategy, new business & market development, and raising of capital. Though the Grace Century members’ network, almost $10 million of funding has been secured for Provia.
Read Provia’s full press release on Scott’s apportionment here.
We recently reported the existing news that our portfolio partner, Provia Laboratories LLC (Provia), had engaged US Capital Partners Inc. (US Capital) as its strategic advisor for a $2M capital raise.
The details of the engagement are now available at http://www.provialabs.com/investor-relations.
Prove are planning to utilise the new financing primarily to grow its sales and marketing function to support new products and services.
A full press release on the engagement is now available by clicking on this link.
Scott Wolf, President and Director of Research for Grace Century, commented “Grace Century is thrilled to have handed over the reins to Provia’ s first Institutional funder U.S. Capital. As a Board advisor, we will continue to assist in all other areas, especially in help Provia expand here in the Middle east and Asia.”
Yahoo! Finance News has reported the engagement of marketing services agency eLuminate by MediXall.
MediXall, who are the medical network arm of Grace Century Electronic Medical Records (EMR) portfolio partner Quantum, have engaged eLuminate to assist with their branding and campaign planning across social media and other digital channels, targeting the South Florida region.
Carl Larsen, EVP and Chief Operating Officer of MediXall, commented, “A key element of our successful launch will be securing a critical mass of both providers and consumers to the platform. We are confident that the talented team from eLuminate Marketing will guide us in reaching our goals of at least 1,000 providers and 100,000 consumers to the platform within two months following official launch. eLuminate is also working closely with the MediXaid development team to ensure brand consistency and the highest quality of User Interface and User Experience — absolutely key elements to our success.”
Read the full story on Yahoo! Finance News here.
MediXall, the medical services member network for the of Grace Century Electronic Medical Records (EMR) project partner Quantum, have just filed their 10-K report. Highlights include:
- The creation of the MediXaid Platform (the “MediXaid Platform”), which has developed a region by region medical services and products e-Marketplace to allow purchasers of products and services to solicit bids from vendors based on location, quality, customer satisfaction results and best value.
- Detail on the uniqueness of MediXall’s offering with regarding to offering the full range of medical equipment, medical devices, products and services credentialed in accordance with healthcare industry standards,and how their approach is a game-changer in comparison to the alternatives currently available in the market.
Read the full report filing here.
Once again, Store-A-Tooth is in the news.
Recently, Store-A-Tooth – the dental stem cell storage system created by Grace Century project partner Provia – started accepting Canadian teeth to be frozen and stored in its Massachusetts lab, which stimulated new media attention and further opinion from medical professionals, as recent article on Global News reported.
Dr. Joe Laning is Provia’s chief technology officer, and he recently said “Cellular medicine is going to be a big part of what we rely on to rebuild broken parts of the body. Theoretically, I think (teeth stem cells) would be used for reconstituting organ function or to build bone.”
Dr. Laning says teeth should be transited to the company’s special transport kit within 48 hours of being pulled to ensure the best results in terms. So far, 60 Canadians have sent their baby teeth to Store-A-Tooth.
Read the fill story and watch the video on Global News here.
A recent article in Business Insider looks at what Americans are currently paying for their healthcare – and the conclusion is that the average American is paying than ever before.
According to the article, more than 50% of American workers pay up to $1,000 up front for their healthcare plans – and this cost runs into several thousand dollars when it comes to specialist services such as getting an X-ray or MRI.
In addition, these costs can escalate significantly if the procedure takes place in a hospital compared to an imaging centre – the research upon which the report is based, which surveyed over 14,000 locations, states that hospital MRI rates were significantly dearer than a stand-alone imaging center.
Scott Wolf, President and Director of Research for Grace Century said “Costs depending on where you go is the whole logic behind our portfolio projects idea for Medxiall. The Business Insider article explains this clearly”
Read the full article here.
Transporting stem cell cultivation to the earth’s orbit could play a key role in the faster rate of growth of stem cells for clinical use, according to a recent article in the International Business Times
Preliminary research has shown that the microgravity environment of the International Space Station actively increases the growth rate of stem cell, and researchers have now confirmed that human stem cell are being cultivated on the ISS for trials back on earth.
The trial are specifically researching mesenchymal stem cells (found in the bone marrow), hematopoietic stem cells (which can grow into all other blood cells) and leukemia cancer stem cells (responsible for leukemia, or cancer of blood-forming tissues).
Abba Zubair, a researcher at the Mayo Clinic in Jacksonville, Florida who is directly involved in the research said “What is unique about this investigation is that we are not only looking at the biology of the cells and how they grow, but focusing on application, how we can use them to treat patients”.
In a statement, NASA said that the long term goals of the research were to develop a safe and reliable clinical grade stem cell bioreactor in space for commercial use and to understand the biology of stem cells and the progression of cancer stem cells.
Scott Wolf, Director of Research for Grace century commented ”It’s only a matter of time before stem cells are regularly cultivated in this manner, given their massive potential for effective clinical treatment of many diseases”
Read the full article here.
MediXall Group Inc. ( OTCQB : MDXL ) has reported a successful launch of its program to recruit and enlist licensed and certified Diagnostic Centers, medical services, medical product providers and Physician Practices to its Member Network. According to an article on Yahoo! Finance News, the initiative has been a success with, several Medical Centers joining the program.
MediXall Group Founder and Chairman, Mr. Noel J. Guillama, said “An estimated 10 percent of US citizens do not have any health insurance and another estimated 27 percent of the U.S. population have high deductible health care plans.” MediXall’s business plan is based on bringing competitive pricing and availability of medical services directly to the consumer, and the reception from practice managers to the Company’s plans has been reflected in the strong embracement of the member network program.
Guillama added “The online marketplace is a well-established model for utilizing the power of competition to empower the consumer, we are now bringing this model to healthcare, in an era of growing deductibles and escalating healthcare costs,”
Grace Century CEO and Director of Research commented“Medixall begins the construction of its network by enlisting its first group of participants. This is the first incubator of our portfolio company, the Quantum Group, and a meaningful first step of improving healthcare access and choice, while lowering costs””
Read the full story on Yahoo! Finance News here.